Pulmonary FunctionNCT06663800
Additional Effects of Ujjayi Pranayama
A study testing Ujjayi Paranayama and Standard Protocol in people with Pulmonary Function and Coronary Artery Disease, run by Riphah International University at 1 site in Pakistan.
Trial summary
Studying the impact of Ujjayi pranayama on post-Coronary Artery Bypass Grafting (CABG) patients has the potential to positively influence healthcare. This research fosters a patient-centered approach, enhancing cardio respiratory function. Read more about this study
- Who is it for?
- Ages 35 to 60 years
- Conditions the study is for
- Pulmonary Function, Coronary Artery Disease
- What is being tested?
- Ujjayi Paranayama and Standard Protocol
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 sitePakistan
- Study dates
- 28 Oct 2024to 18 Jan 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Participants who have 1st post op Day
- Hemodynamically stable \& well oriented patient
- Extubated Patient
- Voluntary based patients
- After approval of surgeon CABG patient were recruited
- Tachypnea
Who cannot join
- Hemodynamically unstable,
- Uncontrolled Hypertension,
- MSK disease,
- Any previous history of tuberculosis,
- Neurological disease ,
- Acute exacerbation of COAD \& Asthma Attack,
Show all 10Show fewer
- Any trauma, anxiety or Rib fracture case ,
- During surgery complaint of graft failure ,
- Unwilling to participate ,
- Postural Hypotension.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Iqbal Tariq, MSCPPT contact
Pakistan1 site
Railway general hospital
Rawalpindi, Punjab Province, 46060
Ume Kulsoom, MSCPPT
About this study
Official title: Additional Effects of Ujjayi Pranayama on Pulmonary Function in Post Coronary Artery Bypass Graft
Studying the impact of Ujjayi pranayama on post-Coronary Artery Bypass Grafting (CABG) patients has the potential to positively influence healthcare. This research fosters a patient-centered approach, enhancing cardio respiratory function. Patient education on these practices can empower individuals, actively contributing to their recovery and overall well-being.
Read the detailed description
. Exercises such as Ujjayi pranayama lower heart rate and benefit high blood pressure sufferers. To determine additional effects of Ujjayi pranayama on pulmonary function in post coronary artery bypass Graft (CABG).
- Conditions
- Pulmonary Function, Coronary Artery Disease
- Being tested
- Ujjayi Paranayama, Standard Protocol
- Keywords
- Ujjayi Paranyama, Coronary artery bypass grafting, Pulmonary Function
- Medical subject headings
- Coronary Artery Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ujjayi ParanayamaOther
Inhale or breathe in slowly while taking a deep, prolonged breath through both nostrils. As you inhale, attempt to tighten your throat and feel the air in your throat. Air should not come into contact with the interior of the nose. When air enters the throat, an odd sound is made. Allow the breath to be loose and easy while you slightly tighten the back of your throat and hiss lightly as you breathe in and out. The sound isn't forced, but it should be loud enough for someone to hear you if they were close. Now close your right nostril and release the breath through your left. As you exhale, try making the sound HHHHHAAAA
Standard ProtocolOther
Control Group will perform Deep Breathing Adhering to a FITT model protocol, with a frequency of 5 days. Intensity set at 8 repetitions, duration range from 10 to 15 minutes
| Study group | Role | What they receive |
|---|---|---|
| arm:1 Pranayama | Experimental | Arm:1 Additional effects of Ujjayi Pranayama Receives: Other: Ujjayi Paranayama |
| arm: 2 (standard protocol) | Other | Arm:2 (standard protocol) Receives: Other: Standard Protocol |
What is being measured
The primary outcome is the main question the study is designed to answer.
Borg dyspnea
(Modified CR-10 is used to assess the degree of dyspnea, rated from 0 to 10. Zero means nothing at all, 0.5=extremely slight, 1=very slight, 2=slight, 3=moderate, 4=somewhat severe, 5=severe, 7=very severe, 9=extremely severe (almost maximal)
Measured: 5days
PFT
Spirometer is simple test used to help diagnose and monitor certain lung conditions by measuring how much air you can breathe out in one forced breathe. Which is a small machine attached by a cable to a mouthpiece. This spirometer yielded generally reproducible results that were generally valid compared to laboratory-based spirometry. The use of this handheld spirometer in clinical, occupational, and research settings seems justified
Measured: 5days
Secondary outcomes (1)
Cardiac monitors
After 5, 10, 15, 20, and 30 minutes of pranayama in the study group and without pranayama in the control group, recordings of HR, SBP, DBP, RR, SpO2
Measured: 5days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Oct 2024
- Study start28 Oct 2024 (estimated)
- Primary completion15 Dec 2024 (estimated)
- Study completion18 Jan 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pulmonary FunctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 36 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Maria Razzaq, MSCPPT, Principal investigator, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06663800
- Sponsor's protocol ID
- REC/MSPT0193 Kulsoom
- Status last verified
- Oct 2024
- First submitted
- 23 Oct 2024
- Last updated
- 29 Oct 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: maintaining confidentiality
Study at a glance
From the registry record, last updated by the sponsor on 29 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Additional Effects of Ujjayi Pranayama on Pulmonary Function in Post Coronary Artery Bypass Graft
- ClinicalTrials.gov ID
- NCT06663800
- Acronym / sponsor ID
- REC/MSPT0193 Kulsoom
- Conditions
- Pulmonary Function, Coronary Artery Disease
- Keywords
- Ujjayi Paranyama, Coronary artery bypass grafting, Pulmonary Function
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 36 participants (estimated)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 28 Oct 2024 (estimated)
- Primary completion
- 15 Dec 2024 (estimated)
- Study completion
- 18 Jan 2025 (estimated)
- First posted
- 29 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Studying the impact of Ujjayi pranayama on post-Coronary Artery Bypass Grafting (CABG) patients has the potential to positively influence healthcare. This research fosters a patient-centered approach, enhancing cardio respiratory function. Patient education on these practices can empower individuals, actively contributing to their recovery and overall well-being.
Detailed description
. Exercises such as Ujjayi pranayama lower heart rate and benefit high blood pressure sufferers. To determine additional effects of Ujjayi pranayama on pulmonary function in post coronary artery bypass Graft (CABG).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| arm:1 Pranayama | Experimental | Other: Ujjayi ParanayamaArm:1 Additional effects of Ujjayi Pranayama |
| arm: 2 (standard protocol) | Other | Other: Standard ProtocolArm:2 (standard protocol) |
Who may qualify
- Ages
- 35 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Participants who have 1st post op Day
- Hemodynamically stable \& well oriented patient
- Extubated Patient
- Voluntary based patients
- After approval of surgeon CABG patient were recruited
Key exclusion criteria (10 listed)
- Hemodynamically unstable,
- Uncontrolled Hypertension,
- MSK disease,
- Any previous history of tuberculosis,
- Neurological disease ,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ujjayi ParanayamaInhale or breathe in slowly while taking a deep, prolonged breath through both nostrils. As you inhale, attempt to tighten your throat and feel the air in your throat. Air should not come into contact with the interior of the nose. When air enters the throat, an odd sound is made. Allow the breath to be loose and easy while you slightly tighten the back of your throat and hiss lightly as you breathe in and out. The sound isn't forced, but it should be loud enough for someone to hear you if they were close. Now close your right nostril and release the breath through your left. As you exhale, try making the sound HHHHHAAAA | Other | arm:1 Pranayama |
| Standard ProtocolControl Group will perform Deep Breathing Adhering to a FITT model protocol, with a frequency of 5 days. Intensity set at 8 repetitions, duration range from 10 to 15 minutes | Other | arm: 2 (standard protocol) |
Primary outcome
Borg dyspnea
Time frame: 5days
(Modified CR-10 is used to assess the degree of dyspnea, rated from 0 to 10. Zero means nothing at all, 0.5=extremely slight, 1=very slight, 2=slight, 3=moderate, 4=somewhat severe, 5=severe, 7=very severe, 9=extremely severe (almost maximal)
PFT
Time frame: 5days
Spirometer is simple test used to help diagnose and monitor certain lung conditions by measuring how much air you can breathe out in one forced breathe. Which is a small machine attached by a cable to a mouthpiece. This spirometer yielded generally reproducible results that were generally valid compared to laboratory-based spirometry. The use of this handheld spirometer in clinical, occupational, and research settings seems justified
1 secondary outcome
Cardiac monitors
Time frame: 5days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Oct 2024.
- Individual participant dataSharing planned: No. maintaining confidentiality
Related trials for Pulmonary Function
Not yet recruitingPhase 2
Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients
COPD, Chronic Obstructive Pulmonary Disease (COPD)
RecruitingPhase 2
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension (PAH)
Active, not recruitingPhase 3
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
Functioning Pancreatic Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm
RecruitingObservational study
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
Pulmonary Disease, Pulmonary Hypertension
Not yet recruiting
Bedside Assessment of Right Ventricular Output Lying in Prone Or Supine
Right Ventricular Function, Prone Position
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Iqbal Tariq, MSCPPT contact
Maria Razzaq, MSCPPT principal investigator
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Ujjayi Paranayama and Standard Protocol in people with Pulmonary Function and Coronary Artery Disease, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 29 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Maria Razzaq, MSCPPT (03431597909, maria.razzaq@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Borg dyspnea (time frame: 5days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2024.